New blood test claims to detect 50-plus cancers before symptoms

A medical expert cautions that while the Galleri blood test can screen for over 50 cancers, there is currently no clinical evidence that it reduces cancer-related mortality. The author emphasizes that early detection does not always equate to better patient outcomes and warns against over-reliance on the test.
Why it matters
It highlights the gap between medical innovation and proven clinical efficacy, which is critical for public health policy and patient expectations.
While a blood test may be relatively safe, the consequences of its results can be far riskier. Douglas Sacha/Moment New blood test claims to detect 50‑plus cancers before symptoms – but there’s no evidence it can reduce your risk of dying from cancer Published: November 9, 2026 1.43pm GMT https://theconversation.com/new-blood-test-claims-to-detect-50-plus-cancers-before-symptoms-but-theres-no-evidence-it-can-reduce-your-risk-of-dying-from-cancer-293409 https://theconversation.com/new-blood-test-claims-to-detect-50-plus-cancers-before-symptoms-but-theres-no-evidence-it-can-reduce-your-risk-of-dying-from-cancer-293409 Link copied Share article Share article
Copy link Email Bluesky Facebook WhatsApp Messenger LinkedIn X (Twitter) Print article
Cancer isn’t the leading cause of death in the United States ; heart disease ranks first in that regard. But it’s cancer that strikes fear into the hearts of many Americans.
Cancer can take an excruciating toll on its millions of victims and their family members. Cancer treatments are often highly toxic, and the disease is increasingly striking people at younger ages , which is why it accounts for more years of potential life lost than heart disease.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in